Clinical Association Between Behçet Syndrome, Cytopenia, and Acquired Trisomy 8: a New Clinical Syndrome?

Yan Shen,Dan Luo,Hai-fen Ma,jian-fei Cai,Jun Zou,Zhi-jun Bao,Jian-long Guan

DOI: https://doi.org/10.21203/rs.3.rs-182539/v1

2021-01-01

Abstract:Abstract Objectives: Behçet syndrome (BS) is heterogeneous with clinical variability across ethnicities and geographic locations. This study analyzed the clinical characteristics of BS associated with cytopenia and trisomy 8.Methods: This was a retrospective study of Chinese BS patients in the Shanghai Behçet’s disease database who were diagnosed with cytopenia and trisomy 8 between October 2012 and April 2019. All subjects fulfilled the International Study Group (ISG) criteria or the International Criteria for Behçet’s Disease (ICBD).Results: Twenty-one patients with BS had cytopenia with trisomy 8; 16 (16/21, 76.2%) were diagnosed with myelodysplastic syndrome (MDS). Compared with 1,147 patients with BS without cytopenia, patients with BS and trisomy 8/cytopenia were more likely to be female (23.8% vs 51.8%,p= 0.011), older (37.9 ± 12.8 vs 45.1 ± 12.0, p = 0.007), have fewer skin lesions (33.3% vs 56.7%,p= 0.033), fever (52.4% vs 1.1%, p < 0.001), have higher C-reactive protein, have higher erythrocyte sedimentation rate (ESR), and display a higher rate of gastrointestinal (GI) ulceration (61.9% vs 9.2%, p < 0.001). By contrast, they had a lower leukocyte count, lower hemoglobin levels, and a lower platelet count (p < 0.05 for all comparisons). Ulcers in the ileocecal region were more frequently seen in intestinal patients with BS with trisomy 8 than in patients with BS without cytopenia (100.0% vs 41.8%; p = 0.002). Compared with 54 patients with MDS without BS symptoms, those with BS and trisomy 8-cytopenia were more likely to be female (23.8% vs 70.4%, p< 0.001) and younger (37.9 ± 12.8 vs 67.2 ± 12.4, p= 0.001). In the follow-up, three patients with BS with trisomy 8 (3/21, 14.3%) died, which is a higher rate than in patients with BS (5/1147, 0.44%) and much lower than in patients with MDS (13/54, 24.1%).Conclusions: The data on patients with BS with cytopenia and trisomy 8 were different from BS or MDS in epidemiology, clinical performance, and prognosis. BS with cytopenia and acquired trisomy 8 may be a new clinical syndrome.